CCL2 and amyotrophic lateral sclerosis: Clinical studies have also correlated MCP1/CCR2 levels with ALS symptoms and progression, reporting decreased levels of peripheral mononuclear cells expressing CCR2 in ALS patients especially with limb onset [47] and positive correlation between increased expression of MCP1 and ALS symptoms [48].